.jpg)
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
There are few areas of the healthcare space that are causing as much excitement, or have as much potential, as CRISPR.
Bioinformatics is transforming personalised care for cancer and rare diseases and aiding in novel drug discovery. In this article, I wanted to highlight the work and progress being made by some of the top companies in the space.
In this clip, I talk about how acting fast is crucial to securing the very best talent in life sciences.
.jpg)
In this clip, I discuss the skills and people that are in demand within the life science industry.
.jpg)
In this clip, I talk about how small companies can beat the larger corporations for talent. They just need to show off what makes them different, that they're people-focused and they can be flexible.
In this live episode, join life science recruitment experts Eleanor Doolin and Adam Butler as they discuss how the best businesses from across the life science space are winning the war for talent.
.jpg)
There’s optimism throughout all the markets we serve and to celebrate this we asked our CM Life Science team what they think we can expect from the year ahead in life sciences. Here's what they said...
.jpg)
With such a strong 2019, 2020 was expected to be a ‘mega year’ for life science companies with a reported $1.4 trillion in firepower at their disposal for M&As. However, COVID-19 gave us an unexpected twist.
.jpg)
What does AI mean for drug discovery? This question and many others was answered by three AI experts in our latest CM Life Science webinar.
For this episode of CM Conversations, our Director of Operations Tom Maskill spoke with QIAGEN CEO Thierry Bernard.
.jpg)
Only 30% of executive positions and 18% of board seats are held by women in biotech. I spoke to industry expert, Melissa Gammell, to find out where we're going wrong, how we get more women into biotech and how we keep them there.
In this episode of CM Conversations, our lab equipment specialist Lucy Smith spoke with Melissa Gammell, Vice President of Business Development at Matphil Technologies about the challenges facing women in biotech.
Cytosurge's tiny syringes are a game changer for the single cell genomic and gene editing applications; since patenting the technology in 2009 the company has gone from strength to strength.
.jpg)
In this episode, our specialist in the lab equipment space, Lucy Smith, spoke with CEO of Elementar Americas Ryan Titmas. Lucy spoke to Ryan about what it takes to get to the top, as well as some of the lessons he’s learned in his career so far.
As businesses prioritise the wellbeing of their employees, the concept of working a 4 day week is shifting from distant pipedream to reality for a range of organisations around the world.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting,
When we talk about genomics hubs, then usually we’d be talking about Oxbridge, Boston or Silicon Valley thanks to success stories like 10x Genomics, Illumina or Solexa. However, as the technology needed to conduct genomic R&D becomes more accessible
In the US alone, a report by the Centers for Disease Control and Prevention (CDC) in March this year highlighted how 2.8 million antibiotic-resistant infections occur each year, leading to the deaths of more than 35,000 people.
One of the biggest partnering events in the life science calendar Bio-Europe Spring, was scheduled to take place in Paris from March 23 – 27 this year. That all changed with the emergence of COVID-19...
.png)
Heading into the proactive world of personalised care, data insights are providing us with more effective, targeted and preventative treatments for patients.
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.
In the last decade the amount of medical data we have access to has exploded. So much so that just interpreting, processing and gaining insights from this data has turned into a whole new area of study and investment - bioinformatics.
Exciting times lie ahead for companies in the precision medicine software market, as a market growth of 11.5% is expected by 2024.
At the end of 2017 we wrote an article about bioinformatics, as an introduction to the technology, major players and current goings-on in the market. The article was received really well, provoking some really interesting conversations, but one...
The Next Generation Sequencing (NGS) industry is still young, but as more companies develop their own systems we’re now seeing new applications emerge for the technology. A wide variety of businesses and industries are thinking outside the tradit...
Collaborations can produce amazing results. When the Wright Brothers put their heads together, they learned how to fly. When Lennon and McCartney met in 1957, pop music was changed forever.
In the digital age we live in, information is everything. Facebook make billions through advertising, purely because of the information they collect from us about our habits, searches and interests.
Bioinformatics is an incredibly exact, yet complicated science. We wanted to dig deeper into exactly what it is, where it is in development, who’s doing it and what purpose it serves. We’re not biologists, computer scientists or bioinformaticians....
